Biopharma company Icosavax goes public

Icosavax, a biopharmaceutical company, has raised about $182 million for its IPO after pricing its over 12.1 million shares at $15 per share.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this